Syngene International Limited Market Cap ($1.79 Billion)
Market Cap & Net Worth: Syngene International Limited (SYNGENE)
Syngene International Limited market cap. Syngene International Limited (NSE:SYNGENE) has a market capitalization of $1.79 Billion (Rs165.89 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #6308 globally and #284 in its home market, demonstrating a 12.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Syngene International Limited's stock price Rs412.95 by its total outstanding shares 401715908 (401.72 Million). Also see cash efficiency ratio of Syngene International Limited for how efficiently the company converts equity into cash flow.
Syngene International Limited Market Cap History (2015–2026)
Syngene International Limited market cap history from 2015 to 2026. Data shows growth from $894.51 Million to $1.79 Billion (7.55% CAGR). Check Syngene International Limited stock price for real-time trading data and today's change.
Index Memberships
Syngene International Limited is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$2.99 Trillion | 0.06% | #251 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$119.17 Billion | 1.51% | #12 of 20 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$657.41 Billion | 0.27% | #107 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.08 Trillion | 0.17% | #162 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.08 Trillion | 0.06% | #246 of 750 |
Weight: Syngene International Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Syngene International Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Syngene International Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Syngene International Limited annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.08x
Syngene International Limited's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.57x
Syngene International Limited's market cap is 0.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.21 Billion | $11.07 Billion | $2.41 Billion | 0.11x | 0.50x |
| 2017 | $1.17 Billion | $12.01 Billion | $2.87 Billion | 0.10x | 0.41x |
| 2018 | $1.21 Billion | $14.23 Billion | $3.05 Billion | 0.09x | 0.40x |
| 2019 | $1.39 Billion | $18.26 Billion | $3.32 Billion | 0.08x | 0.42x |
| 2020 | $2.77 Billion | $20.12 Billion | $4.12 Billion | 0.14x | 0.67x |
| 2021 | $2.68 Billion | $21.84 Billion | $4.05 Billion | 0.12x | 0.66x |
| 2022 | $2.54 Billion | $26.04 Billion | $3.96 Billion | 0.10x | 0.64x |
| 2023 | $3.04 Billion | $31.93 Billion | $4.64 Billion | 0.10x | 0.66x |
| 2024 | $3.73 Billion | $34.89 Billion | $5.10 Billion | 0.11x | 0.73x |
| 2025 | $2.83 Billion | $36.42 Billion | $4.96 Billion | 0.08x | 0.57x |
Competitor Companies of SYNGENE by Market Capitalization
Companies near Syngene International Limited in the global market cap rankings as of November 4, 2026. Also see SYNGENE total asset value for a full breakdown of the balance sheet.
Key companies related to Syngene International Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $161.03 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #493 globally with a market cap of $54.62 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #539 globally with a market cap of $50.18 Billion USD ( CN¥342.92 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $682.65 |
| #143 | Danaher Corporation | NYSE:DHR | $161.03 Billion | $227.97 |
| #493 | Natera Inc | NASDAQ:NTRA | $54.62 Billion | $378.92 |
| #539 | WuXi AppTec Co Ltd | SHG:603259 | $50.18 Billion | CN¥138.65 |
Market Capitalization of Syngene International Limited (2015–2026)
Market capitalization of Syngene International Limited from 2015 to today. Between 2015 and today, Syngene International Limited's market cap moved from $894.51 Million to $ 1.79 Billion, with a yearly change of 7.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.79 Billion | -36.57% |
| 2025 | Rs2.83 Billion | -24.17% |
| 2024 | Rs3.73 Billion | +22.60% |
| 2023 | Rs3.04 Billion | +19.91% |
| 2022 | Rs2.54 Billion | -5.46% |
| 2021 | Rs2.68 Billion | -3.08% |
| 2020 | Rs2.77 Billion | +99.78% |
| 2019 | Rs1.39 Billion | +14.48% |
| 2018 | Rs1.21 Billion | +3.66% |
| 2017 | Rs1.17 Billion | -3.45% |
| 2016 | Rs1.21 Billion | +35.23% |
| 2015 | Rs894.51 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Syngene International Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.79 Billion USD |
| MoneyControl | $1.79 Billion USD |
| MarketWatch | $1.79 Billion USD |
| marketcap.company | $1.79 Billion USD |
| Reuters | $1.79 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more